Lin Cai

540 total citations
29 papers, 305 citations indexed

About

Lin Cai is a scholar working on Immunology, Dermatology and Epidemiology. According to data from OpenAlex, Lin Cai has authored 29 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Dermatology and 9 papers in Epidemiology. Recurrent topics in Lin Cai's work include Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (8 papers) and Spondyloarthritis Studies and Treatments (4 papers). Lin Cai is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (8 papers) and Spondyloarthritis Studies and Treatments (4 papers). Lin Cai collaborates with scholars based in China, Australia and United States. Lin Cai's co-authors include Jianzhong Zhang, Gwendolyn L. Gilbert, Yan Zhao, Fei Zhou, Shahin Oftadeh, Xiaoping Xu, Xiaoyang Liu, Meng Xiao, Fanrong Kong and Min Zheng and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Medical Genetics and BMJ Open.

In The Last Decade

Lin Cai

26 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Cai China 10 113 87 72 51 37 29 305
Atsushi Harimaya Japan 12 63 0.6× 88 1.0× 26 0.4× 61 1.2× 16 0.4× 24 390
Joseph S. Ainscough United Kingdom 7 191 1.7× 49 0.6× 125 1.7× 103 2.0× 19 0.5× 8 355
Yun Ge China 6 136 1.2× 71 0.8× 27 0.4× 79 1.5× 15 0.4× 8 261
Nicholas J. Shubin United States 11 330 2.9× 164 1.9× 18 0.3× 63 1.2× 22 0.6× 16 483
Takuro Nii Japan 8 85 0.8× 49 0.6× 18 0.3× 176 3.5× 47 1.3× 25 345
Hardis Rabe Sweden 12 168 1.5× 36 0.4× 22 0.3× 107 2.1× 12 0.3× 33 405
Huaqiong Huang China 13 149 1.3× 94 1.1× 10 0.1× 74 1.5× 10 0.3× 41 440
Isabella Haslinger Austria 7 221 2.0× 63 0.7× 8 0.1× 150 2.9× 17 0.5× 13 367
Ye Yan China 12 58 0.5× 153 1.8× 9 0.1× 87 1.7× 47 1.3× 32 339
Swati Patel India 14 108 1.0× 75 0.9× 8 0.1× 119 2.3× 12 0.3× 22 531

Countries citing papers authored by Lin Cai

Since Specialization
Citations

This map shows the geographic impact of Lin Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Cai more than expected).

Fields of papers citing papers by Lin Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Cai. The network helps show where Lin Cai may publish in the future.

Co-authorship network of co-authors of Lin Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Cai. A scholar is included among the top collaborators of Lin Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Cai. Lin Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Zheng, Zhanglei Mu, Yan Zhao, Jianzhong Zhang, & Lin Cai. (2025). A real-world study of ixekizumab use patterns, switching and efficacy in patients with plaque psoriasis. Archives of Dermatological Research. 317(1). 614–614.
2.
3.
Zhang, Heng, Yan Zhao, Lingxia Wang, et al.. (2025). Eczematoid paradoxical reaction in psoriasis patients following secukinumab. Chinese Medical Journal. 138(8). 997–999.
4.
Zhao, Zheng, Zhanglei Mu, Yan Zhao, Jianzhong Zhang, & Lin Cai. (2024). Efficacy, drug survival, safety and metabolic parameters of ixekizumab in patients with moderate-to-severe psoriasis in China: A two-year real-world study. International Immunopharmacology. 143(Pt 2). 113474–113474. 3 indexed citations
5.
Zhao, Yan, Lin Cai, Zhanglei Mu, et al.. (2024). Tapinarof inhibits psoriatic inflammation through inducing tolerogenic dendritic cells and Foxp3+ Tregs. Chinese Medical Journal. 137(23). 2877–2879. 1 indexed citations
6.
Liu, Xiaoyang, Yan Zhao, Zhanglei Mu, et al.. (2023). The Combination of IL-6, PLR and Nail Psoriasis: Screen for the Early Diagnosis of Psoriatic Arthritis. Clinical Cosmetic and Investigational Dermatology. Volume 16. 1703–1713. 5 indexed citations
7.
Zhao, Yan, Lin Cai, Xiaoyang Liu, Heng Zhang, & Jianzhong Zhang. (2021). Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis: a real-life cohort study. Chinese Medical Journal. 134(11). 1324–1328. 12 indexed citations
8.
Cai, Lin, Jianzhong Zhang, Min Zheng, Shifa Zhang, & Manmath Patekar. (2021). Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis. Chinese Medical Journal. 134(21). 2629–2631. 3 indexed citations
9.
Dong, Wen‐Liang, Xiaoyan Nie, Jiaxue Wang, et al.. (2020). Randomised, double-blind, multicentre, phase Ⅰ/Ⅱ dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocol. BMJ Open. 10(11). e039067–e039067. 5 indexed citations
10.
Zhao, Yan, et al.. (2019). Tetra-arsenic tetra-sulfide ameliorates lupus syndromes by inhibiting IL-17 producing double negative T cells. Dermatologic Therapy. 32(4). e12849–e12849. 8 indexed citations
11.
Liu, Xiaoyang, Jiang Jin, Si Zhang, et al.. (2019). Dermoscopy of cutaneous metastases from primary hepatocellular carcinoma. Chinese Medical Journal. 132(17). 2131–2132. 3 indexed citations
12.
Chen, Xi, Bo Li, Fenglin Zhuo, et al.. (2019). Mycobacterium abscessus cutaneous infection secondary to botulinum toxin injection: A report of 2 cases. JAAD Case Reports. 5(11). 982–984. 11 indexed citations
13.
Zhang, Si, Xiaoyang Liu, Lin Cai, Chen Zhou, & Jianzhong Zhang. (2019). A case of lupus miliaris disseminatus faciei after allogeneic hematopoietic stem cell transplantation. Chinese Medical Journal. 132(17). 2133–2134. 1 indexed citations
14.
Liu, Xianyong, et al.. (2019). [Drug-induced toxic epidermal necrolysis with secondary aspergillus fumigatus infection: a case report].. PubMed. 51(5). 977–980. 2 indexed citations
15.
Zhao, Zheng, et al.. (2016). Expressions of Antimicrobial Peptides LL-37, Human Beta Defensin-2 and -3 in the Lesions of Cutaneous Tuberculosis and Tuberculids. Chinese Medical Journal. 129(6). 696–701. 11 indexed citations
16.
Cai, Lin, Jie Zheng, Min Zheng, et al.. (2016). Efficacy and safety of adalimumab in Chinese patients with moderate‐to‐severe plaque psoriasis: results from a phase 3, randomized, placebo‐controlled, double‐blind study. Journal of the European Academy of Dermatology and Venereology. 31(1). 89–95. 79 indexed citations
17.
18.
Ma, Xiaolei, et al.. (2014). A case of an adult Langerhans cell sarcoma. International Journal of Dermatology. 55(1). 92–96. 4 indexed citations
19.
Yuan, Yong, Juan Zhang, Lin Cai, et al.. (2013). Leptin induces cell proliferation and reduces cell apoptosis by activating c-myc in cervical cancer. Oncology Reports. 29(6). 2291–2296. 25 indexed citations
20.
Cai, Lin, Fanrong Kong, Peter Jelfs, Gwendolyn L. Gilbert, & Vitali Sintchenko. (2009). Rolling circle amplification and multiplex allele-specific PCR for rapid detection of katG and inhA gene mutations in Mycobacterium tuberculosis. International Journal of Medical Microbiology. 299(8). 574–581. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsushi Harimaya Breakdown of academic impact, for papers by Joseph S. Ainscough Breakdown of academic impact, for papers by Yun Ge Breakdown of academic impact, for papers by Nicholas J. Shubin Breakdown of academic impact, for papers by Takuro Nii Breakdown of academic impact, for papers by Hardis Rabe Breakdown of academic impact, for papers by Huaqiong Huang Breakdown of academic impact, for papers by Isabella Haslinger Breakdown of academic impact, for papers by Ye Yan Breakdown of academic impact, for papers by Swati Patel
Rankless by CCL
2026